Learn more and register here.

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T cell engagers and TIL Therapies. FREE for healthcare professionals, students, patients and patient advocates. 

New for 2025

• View presentations on recent studies and approvals of cellular therapies for solid tumors, including TCR-engineered T cells and CAR T cells for pediatric brain malignancies.
• Cover clinical trials and future directions of the newly approved DLL-targeting T cell engager for lung cancer.
• Explore current cellular therapies options, including TILs for immune checkpoint inhibitor-resistant melanoma.